A Study of TYK-00540 in Adult Patients With Solid Tumors
NCT06246071 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 156
Last updated 2024-02-07
Summary
The primary objective of this study is to evaluate the safety and tolerability of TYK-00540, with dose-escalation stage and dose-expansion stage.
Conditions
- Locally Advanced or Metastatic Solid Tumors
Interventions
- DRUG
-
TYK-00540
TYK-00540 PO, BID
Sponsors & Collaborators
-
TYK Medicines, Inc
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-01-02
- Primary Completion
- 2026-12-05
- Completion
- 2026-12-05
Countries
- China
Study Locations
More Related Trials
-
First-in-Human Study of LPM6690176 in Patients With Advanced Solid Tumors.
NCT06240546 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Evaluate the Tolerance, Efficacy and Pharmacokinetics of TQB3454 Tablets
NCT04481607 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study to Evaluate the Tolerance, Efficacy and Pharmacokinetics of TQB3558 Tablets
NCT04408079 ·Status: UNKNOWN ·Phase: PHASE1
-
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TQB3217 Tablets in Subjects With Advanced Malignant Tumors
NCT07291050 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Phase I/II Clinical Study in Patients with Advanced Solid Tumor.
NCT05970016 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3474 Injection
NCT04144855 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3804 in Subjects With Advanced Malignant Tumors
NCT04128085 ·Status: UNKNOWN ·Phase: PHASE1
-
A Clinical Study of TQB3823 in Patients With Advanced Malignant Tumor
NCT05021367 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Safety,Tolerability, Pharmacokinetic,Pharmacodynamics and Efficacy of KY100001 in Patients With Advanced Solid Tumors
NCT04906473 ·Status: UNKNOWN ·Phase: PHASE1
-
Phase 1 Study of Oral TP-1454
NCT04328740 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3602 Capsule
NCT04275583 ·Status: UNKNOWN ·Phase: PHASE1
-
PE0116 and PE0105 Injection in Treatment of Patients With Advanced Solid Tumor
NCT05801237 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Study of the of the Safety and Tolerability of TT-00434 in Patients With Advanced Solid Tumors
NCT04830501 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial of TQB3015 Tablets in Patients With Advanced Malignant Cancer
NCT06165809 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Clinical Trial of TQB3006 Tablets in Patients With Advanced Malignant Cancer
NCT06344351 ·Status: COMPLETED ·Phase: PHASE1
-
A First-in-human of Multiplle Doses of BB-1705 in Subjects With Locally Advanced/Metastatic Solid Tumors
NCT05217693 ·Status: RECRUITING ·Phase: PHASE1
-
A Dose-Escalation Study of SPYK04 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion).
NCT04511845 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Study of IBI3005 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors
NCT06418061 ·Status: RECRUITING ·Phase: PHASE1
-
Clinical Trial of TQB2825 in Subjects With CD20 Positive Hematological Tumors
NCT05489276 ·Status: UNKNOWN ·Phase: PHASE1
-
Efficacy and Safety of TQB2450 Injection Combined With Chemotherapy ± Anlotinib Hydrochloride Capsules for Advanced Endometrial Cancer or Sarcoma of Uterus.
NCT05481645 ·Status: TERMINATED ·Phase: PHASE2
-
A Clinical Trial on the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TQB3019 Capsule in Subjects With Advanced Malignant Tumors
NCT06943677 ·Status: RECRUITING ·Phase: PHASE1
-
To Evaluate the Safety and Tolerability of SYHX2001 in Patients With Advanced or Metastatic Solid Tumors
NCT05407909 ·Status: RECRUITING ·Phase: PHASE1
-
Study Evaluating TTI-237 in Advanced Malignant Solid Tumors.
NCT00195325 ·Status: TERMINATED ·Phase: PHASE1
-
An Open-Label, Multicenter, Phase I Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of YY201 in Patients With Advanced Solid Tumors and Hematological Malignancies
NCT06225856 ·Status: RECRUITING ·Phase: PHASE1
-
Clinical Trial of TQB2618 Injection Combined With TQB2450 Injection in Patients With Advanced Solid Tumors
NCT05645315 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2